Search

everythinglearnresearchcommunity

for

Search:↓

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Female mice are less affected by certain substances that alter alcohol consumption compared to male mice.

Many patients on methotrexate experience significant side effects but still continue the medication.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

LustrivaTM improves hair thickness and reduces facial wrinkles safely.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Acne not improved by usual treatments may indicate a genetic disorder.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Baricitinib works better than methotrexate for severe alopecia areata.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.